serolog
core
compon
surveil
manag
viral
zoonos
viru
neutral
test
gold
standard
serolog
diagnost
requir
larg
volum
serum
high
biosafeti
contain
limit
widespread
use
focus
rabi
lyssaviru
global
import
zoonosi
develop
pseudotyp
microneutr
rapid
fluoresc
focu
inhibit
test
pmrffit
overcom
limit
specif
adapt
exist
microneutr
test
use
green
fluoresc
proteintag
murin
leukemia
viru
pseudotyp
lieu
pathogen
rabi
viru
reduc
need
special
reagent
antigen
detect
enabl
use
lowcontain
laboratori
use
statist
analysi
gener
rapid
quantit
predict
probabl
titer
rabi
viru
neutral
antibodi
microscop
imag
neutral
outcom
use
serum
sampl
domest
dog
neutral
antibodi
titer
estim
use
fluoresc
antibodi
viru
neutral
test
favn
pmrffit
show
moder
sensit
high
specif
despit
small
conflict
titer
predict
correl
across
test
repeat
differ
date
dog
sampl
r
second
dataset
sera
wild
common
vampir
bat
r
n
indic
repeat
test
use
start
volum
serum
estim
titer
singl
dilut
serum
rather
requir
multipl
dilut
end
point
titrat
may
adapt
target
neutral
antibodi
altern
lyssaviru
speci
pmrffit
enabl
highthroughput
detect
rabi
viru
neutral
antibodi
biocontain
set
suit
studi
wild
captiv
anim
larg
serum
volum
obtain
serolog
core
compon
surveil
manag
viral
zoonos
viru
neutral
test
gold
standard
serolog
diagnost
requir
larg
volum
serum
high
biosafeti
contain
limit
widespread
use
focus
rabi
lyssaviru
global
import
zoonosi
develop
pseudotyp
microneutr
rapid
fluoresc
focu
inhibit
test
pmrffit
overcom
limit
specif
adapt
exist
microneutr
test
use
green
fluoresc
proteintag
murin
leukemia
viru
pseudotyp
lieu
pathogen
rabi
viru
reduc
need
special
reagent
antigen
detect
enabl
use
lowcontain
laboratori
use
statist
analysi
gener
rapid
quantit
predict
probabl
titer
rabi
viru
neutral
antibodi
microscop
imag
neutral
outcom
use
serum
sampl
domest
dog
neutral
antibodi
titer
estim
use
fluoresc
antibodi
viru
neutral
test
favn
pmrffit
show
moder
sensit
high
specif
despit
small
conflict
titer
predict
correl
across
test
repeat
differ
date
dog
sampl
r
second
dataset
sera
wild
common
vampir
bat
r
n
indic
repeat
test
use
start
volum
serum
estim
titer
singl
dilut
serum
rather
requir
multipl
dilut
end
point
titrat
may
adapt
target
neutral
antibodi
altern
lyssaviru
speci
pmrffit
enabl
highthroughput
detect
rabi
viru
neutral
antibodi
biocontain
set
suit
studi
wild
captiv
anim
larg
serum
volum
last
decad
seen
surg
newli
emerg
human
virus
origin
wildlif
gfp
fluoresc
next
command
analyz
particl
use
count
total
number
ccbi
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
fluoresc
cell
per
field
ie
infect
cell
command
group
count
white
neighbor
pixel
predetermin
size
area
circular
singl
cell
size
area
circular
count
correspond
number
infect
cell
cell
count
output
convert
standard
spreadsheet
use
python
version
script
python
core
team
script
avail
supplementari
materi
end
imag
process
step
serum
sampl
describ
data
point
consist
number
fluoresc
cell
field
photograph
dilut
figur
b
statist
analys
execut
r
r
core
team
scale
improv
model
converg
serum
dilut
level
two
factor
dilut
random
slope
intercept
term
also
consid
date
test
run
test
date
account
observ
variat
relationship
srig
titer
infect
cell
count
across
date
figur
field
number
within
microscop
well
field
account
variat
cell
count
field
middl
field
field
agglomer
cell
particular
evalu
whether
simpler
singl
dilut
test
produc
compar
result
full
dataset
subset
dilut
binomi
lognorm
model
fit
data
subset
includ
fix
effect
virusinfect
cell
count
random
effect
ident
explain
ie
test
date
field
model
fit
use
packag
bate
et
al
predict
function
use
gener
predict
probabl
srig
concentr
serum
sampl
seroposit
binomi
model
correspond
rvna
titer
lognorm
model
predict
per
field
averag
obtain
result
per
sampl
figur
c
threshold
iuml
posit
use
benchmark
refer
understand
variabl
pmrffit
replic
srig
titer
concentr
curv
produc
differ
date
hereaft
test
test
expect
number
infect
cell
declin
higher
srig
titer
replic
howev
shape
antibodi
decay
curv
vari
across
test
date
figur
iuml
srig
concentr
infect
cell
count
dispers
dilut
dilut
indic
higher
interquartil
rang
iqr
within
test
date
across
srig
concentr
test
date
n
count
comparison
less
dispers
dilut
suggest
dilut
could
precis
downstream
statist
analysi
si
binomi
glmm
accur
predict
seroposit
seroneg
srig
concentr
figur
best
random
effect
binomi
model
includ
random
slope
intercept
test
date
tabl
model
built
dilut
data
onedilut
model
dilut
data
twodilut
model
equival
specif
dilut
model
sensit
versu
figur
b
furthermor
twodilut
binomi
model
fail
correctli
predict
seroposit
control
test
date
confirm
improv
perform
onedilut
model
figur
b
lognorm
glmm
gave
repeat
predict
rvna
titer
dataset
gener
protocol
across
test
date
figur
c
best
lognorm
model
includ
random
intercept
slope
test
date
although
complex
model
lowest
aicc
simpler
model
without
random
intercept
field
tabl
observ
predict
srig
titer
highli
correl
one
twodilut
model
r
figur
c
compar
test
date
ie
onetoon
comparison
correl
onedilut
twodilut
model
test
date
correl
coeffici
similar
suggest
simpler
onedilut
model
suffici
titer
predict
figur
commonli
appli
serolog
test
detect
rvna
titer
challeng
rang
serial
dilut
serum
infecti
rv
process
laborintens
requir
laboratori
capac
grow
larg
quantiti
pathogen
rv
provid
altern
serolog
framework
use
combin
digit
imag
analysi
statist
analysi
estim
presenc
titer
rvna
singl
dilut
use
serum
pmrffit
differ
lyssaviru
neutral
test
sever
key
aspect
use
mlv
rg
pseudotyp
rather
pathogen
rv
allow
pmrffit
perform
contain
laboratori
appropri
cell
cultur
microscopi
facil
addit
gfp
express
signific
sinc
remov
need
fitcconjug
antibodi
reduc
reagent
ccbi
intern
licens
certifi
peer
review
authorfund
made
avail
pmrffit
standard
approach
minim
sourc
error
potenti
reduc
microscop
oper
time
moreov
imag
process
gener
traceabl
perman
electron
record
raw
data
elimin
need
manual
digit
record
field
count
sever
investig
previous
incorpor
imag
process
rv
neutral
test
count
pixel
use
microrffit
make
full
use
quantit
natur
imag
data
obtain
rvna
titer
use
pathogen
rv
rather
viral
pseudotyp
final
distinct
instead
score
microscop
field
well
viru
posit
neg
pmrffit
predict
serolog
statu
rvna
titer
infect
cell
count
singl
serum
dilut
use
statist
model
efficaci
approach
highlight
valu
histor
underutil
quantit
data
cellular
infect
lyssaviru
serolog
model
select
indic
substanti
daytoday
variat
srig
dilut
seri
unsurpris
sinc
viru
neutral
test
biolog
dynam
system
influenc
mani
factor
eg
variabl
humid
incub
technic
manipul
light
condit
microscop
variabl
gfp
express
cell
brigg
et
al
hammami
et
al
kostens
et
al
sinc
statist
approach
handl
variabl
random
effect
test
date
pmrffit
best
suit
larg
number
serum
sampl
requir
test
carri
across
multipl
batch
howev
perform
margin
reduc
run
singl
model
test
date
impli
pmrffit
may
still
use
fewer
sampl
avail
test
see
si
surprisingli
fit
glmm
data
singl
dilut
srig
predict
seroposit
rvna
titer
accur
model
fit
dilut
reduc
perform
twodilut
model
reflect
higher
variabl
dilut
compar
dilut
evidenc
greater
iqr
valu
si
ultim
variabl
like
reflect
higher
stochast
infect
cell
count
lower
serum
concentr
pipet
error
regardless
abil
detect
low
titer
iuml
one
dilut
without
need
conduct
separ
test
screen
titrat
advantag
sinc
manual
effort
materi
reduc
immunoglobulin
hrig
srig
intratest
variat
respect
similarli
timiryasova
et
al
valid
rffit
protocol
variat
among
intratest
repetit
comparison
test
show
higher
repeat
serum
sampl
dog
similar
repeat
serum
sampl
bat
posit
predict
bat
sampl
lower
repetit
conflict
occur
titer
near
threshold
defin
seroposit
sampl
figur
b
si
challeng
repeat
predict
test
higher
repeat
dog
sera
rel
bat
sera
like
relat
presenc
notic
higher
neutral
antibodi
titer
dog
sera
dog
vaccin
compar
bat
sampl
high
predict
titer
iuml
consist
find
kostenz
et
al
also
observ
antibodi
concentr
curv
initi
evid
bend
titer
concentr
iuml
abil
observ
slope
chang
lowest
concentr
serum
iuml
challeng
overal
pmrffit
precis
discrimin
strong
posit
strong
neg
highest
lowest
titer
constantli
predict
consider
point
standard
serolog
method
might
limit
measur
low
rvna
titer
iuml
pmrffit
grant
highli
repeat
approach
titer
valu
use
extern
valid
set
dog
sampl
known
rvna
titer
overal
accuraci
pmrffit
moder
high
discrep
occur
sampl
favn
titer
rang
iuml
observ
sampl
higher
titer
n
previou
analysi
sampl
sera
reach
iuml
threshold
consid
neg
retest
wright
et
al
therefor
disregard
possibl
inaccur
titer
assess
favn
consid
lowtit
detect
even
challeng
classic
approach
titer
predict
favn
test
vari
even
higher
titer
ie
sampl
score
iuml
rang
iuml
repeat
perform
cell
count
fluoresc
cell
construct
databas
fit
statist
model
c
construct
statist
model
two
differ
type
predict
srig
data
fit
hr
fieldswel
ccbi
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
ccbi
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
